Paloma Mateu-Rogell

Dr. Paloma Mateu-Rogell

Instituto Nacional de Perinatología, Mexico City, Ciudad de México, Mexico
+2
orcid

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
10 February 2021 in Cells
Verified
Journal Article
Open access
PDF file
Arturo Flores-PliegoArturo Flores-Pliego
Arturo Flores-Pliego
Jael Miranda GuzmanJael Miranda Guzman
Jael Miranda Guzman
SVSara Vega-Torreblanca
Sara Vega-Torreblanca
YVYolotzin Valdespino-Vázquez
Yolotzin Valdespino-Vázquez
Addy Cecilia Helguera-RepettoAddy Cecilia Helguera-Repetto
Addy Cecilia Helguera-Repetto
GEGuadalupe Estrada-Gutierrez
Guadalupe Estrada-Gutierrez
Clinical manifestations of coronavirus disease 2019 (COVID-19) in pregnant women are diverse, and little is known of the impact of the disease on placental physiology. Severe acute respiratory syndrome coronavirus (SARS-CoV-2) has been detected in the human placenta, and its binding receptor ACE2 is present in a variety of placental cells, including endothelium. Here, we analyze the impact of COVID-19 in placental endothelium, studying by immunofluorescence the expression of von Willebrand factor (vWf), claudin-5, and vascular endothelial (VE) cadherin in the decidua and chorionic villi of placentas from women with mild and severe COVID-19 in comparison to healthy controls. Our results indicate that: (1) vWf expression increases in the endothelium of decidua and chorionic villi of placentas derived from women with COVID-19, being higher in severe cases; (2) Claudin-5 and VE-cadherin expression decrease in the decidua and chorionic villus of placentas from women with severe COVID-19 but not in those with mild disease. Placental histological analysis reveals thrombosis, infarcts, and vascular wall remodeling, confirming the deleterious effect of COVID-19 on placental vessels. Together, these results suggest that placentas from women with COVID-19 have a condition of leaky endothelium and thrombosis, which is sensitive to disease severity.

23 September 2021 in Viruses
Verified
Journal Article
Open access
PDF file
Salvador Espino y SosaSalvador Espino y Sosa
Salvador Espino y Sosa
Raigam Jafet Martinez Martinez-PortillaRaigam Jafet Martinez Martinez-Portilla
Raigam Jafet Martinez Martinez-Portilla
Johnatan TorresJohnatan Torres
Johnatan Torres
Juan Mario Solis ParedesJuan Mario Solis Paredes
Juan Mario Solis Paredes
GEGuadalupe Estrada-Gutierrez
Guadalupe Estrada-Gutierrez
LPLiona C. Poon
Liona C. Poon
Background: In healthy pregnancies, components of the Renin-Angiotensin system (RAS) are present in the placental villi and contribute to invasion, migration, and angiogenesis. At the same time, soluble fms-like tyrosine kinase 1 (sFlt-1) production is induced after binding of ANG-II to its receptor (AT-1R) in response to hypoxia. As RAS plays an essential role in the pathogenesis of COVID-19, we hypothesized that angiogenic marker (sFlt-1) and RAS components (ANG-II and ACE-2) may be related to adverse outcomes in pregnant women with COVID-19; Methods: Prospective cohort study. Primary outcome was severe pneumonia. Secondary outcomes were ICU admission, intubation, sepsis, and death. Spearman’s Rho test was used to analyze the correlation between sFlt-1 and ANG-II levels. The sFlt-1/ANG-II ratio was determined and the association with each adverse outcome was explored by logistic regression analysis and the prediction was assessed using receiver-operating-curve (ROC); Results: Among 80 pregnant women with COVID-19, the sFlt-1/ANG-II ratio was associated with an increased probability of severe pneumonia (odds ratio [OR]: 1.31; p = 0.003), ICU admission (OR: 1.05; p = 0.007); intubation (OR: 1.09; p = 0.008); sepsis (OR: 1.04; p = 0.008); and death (OR: 1.04; p = 0.018); Conclusion: sFlt-1/ANG-II ratio is a good predictor of adverse events such as pneumonia, ICU admission, intubation, sepsis, and death in pregnant women with COVID-19.

29 June 2022 in Frontiers in Pediatrics
Verified
Journal Article
Open access
AHAddy Cecilia Helguera-Repetto
Addy Cecilia Helguera-Repetto
IVIsabel Villegas-Mota
Isabel Villegas-Mota
GAGuadalupe Itzel Arredondo-Pulido
Guadalupe Itzel Arredondo-Pulido
JCJorge Arturo Cardona–Pérez
Jorge Arturo Cardona–Pérez
MLMoises León-Juárez
Moises León-Juárez
CIClaudine Irles
Claudine Irles
Passive transplacental immunity is crucial for neonatal protection from infections. Data on the correlation between neonatal immunity to SARS-CoV-2 and protection from adverse outcomes is scarce. This work aimed to describe neonatal seropositivity in the context of maternal SARS-CoV-2 infection, seropositivity, and neonatal outcomes. This retrospective nested case-control study enrolled high-risk pregnant women with a SARS-CoV-2 RT-PCR positive test who gave birth at the Instituto Nacional de Perinatología in Mexico City and their term neonates. Anti-SARS-CoV-2 IgG antibodies in maternal and cord blood samples were detected using a chemiluminescent assay. In total, 63 mother-neonate dyads (mean gestational age 38.4 weeks) were included. Transplacental transfer of SARS-CoV-2 IgG occurred in 76% of neonates from seropositive mothers. A positive association between maternal IgG levels and Cycle threshold (Ct) values of RT-qPCR test for SARS-CoV-2 with neonatal IgG levels was observed. Regarding neonatal outcomes, most seropositive neonates did not require any mechanical ventilation, and none developed any respiratory morbidity (either in the COVID-19 positive or negative groups) compared to 7 seronegative neonates. Furthermore, the odds of neonatal respiratory morbidity exhibited a tendency to decrease when neonatal IgG levels increase. These results add further evidence suggesting passive IgG transfer importance.

9 May 2022 in Frontiers in Medicine
Verified
Journal Article
Open access
JHJose Antonio Hernandez-Pacheco
Jose Antonio Hernandez-Pacheco
JTJohnatan Torres-Torres
Johnatan Torres-Torres
RMRaigam Jafet Martinez-Portilla
Raigam Jafet Martinez-Portilla
Juan Mario Solis ParedesJuan Mario Solis Paredes
Juan Mario Solis Paredes
GEGuadalupe Estrada-Gutierrez
Guadalupe Estrada-Gutierrez
Salvador Espino y SosaSalvador Espino y Sosa
Salvador Espino y Sosa
Background: Preeclampsia (PE) and COVID-19 share a common vascular–endothelial physiopathological pathway that may aggravate or worsen women's outcomes when both coexist. This study aims to evaluate the association of sFlt-1 levels and adverse maternal outcomes among positive SARS-CoV-2 pregnant women with and without hypertensive disorders of pregnancy (HDP). Methods: We performed a multicenter retrospective cohort study of pregnant women with confirmed SARS-CoV-2 infection that required hospital admission. The exposed cohort comprised women with a diagnosis of an HDP. The primary outcome was a composite definition of adverse maternal outcome. The association between predictors and the main and secondary outcomes was assessed using an elastic-net regression which comprised a Lasso and Ridge regression method for automatic variable selection and penalization of non-statistically significant coefficients using a 10-fold cross-validation where the best model if automatically chosen by the lowest Akaike information criterion (AIC) and Bayesian information criteria (BIC). Results: Among 148 pregnant women with COVID-19, the best predictive model comprised sFlt-1 MoMs [odds ratio (OR): 5.13; 95% CI: 2.19–12.05], and HDP (OR: 32.76; 95% CI: 5.24–205). sFlt-1 MoMs were independently associated with an increased probability of an adverse maternal outcome despite adjusting for HDP. Conclusions: Our study shows that sFlt-1 is an independent predictor of adverse outcomes in women with SARS-CoV-2 despite hypertension status.

28 January 2022 in Viruses
Verified
Journal Article
Open access
PDF file
Johnatan TorresJohnatan Torres
Johnatan Torres
Raigam Jafet Martinez Martinez-PortillaRaigam Jafet Martinez Martinez-Portilla
Raigam Jafet Martinez Martinez-Portilla
Salvador Espino y SosaSalvador Espino y Sosa
Salvador Espino y Sosa
Juan Mario Solis ParedesJuan Mario Solis Paredes
Juan Mario Solis Paredes
JHJose Antonio Hernández-Pacheco
Jose Antonio Hernández-Pacheco
MCManuel Casillas-Barrera
Manuel Casillas-Barrera
Cardiomyocyte injury and troponin T elevation has been reported within COVID-19 patients and are associated with a worse prognosis. Limited data report this association among COVID-19 pregnant patients. Objective: We aimed to analyze the association between troponin T levels in severe COVID-19 pregnant women and risk of viral sepsis, intensive care unit (ICU) admission, or maternal death. Methods: We performed a prospective cohort of all obstetrics emergency admissions from a Mexican National Institute. All pregnant women diagnosed by reverse transcription-polymerase chain reaction (RT-qPCR) for SARS-CoV-2 infection between October 2020 and May 2021 were included. Clinical data were collected, and routine blood samples were obtained at hospital admission. Seric troponin T was measured at admission. Results: From 87 included patients, 31 (35.63%) had severe COVID-19 pneumonia, and 6 (6.89%) maternal deaths. ROC showed a significant relationship between troponin T and maternal death (AUC 0.979, CI 0.500–1.000). At a cutoff point of 7 ng/mL the detection rate for severe pneumonia was 83.3% (95%CI: 0.500–0.100) at 10% false-positive rate. Conclusion: COVID-19 pregnant women with elevated levels of troponin T present a higher risk of death and severe pneumonia.

26 March 2021 in The Journal of Maternal-Fetal & Neonatal Medicine
Verified
Journal Article
Closed access
RHRosa Gabriela Hernández-Cruz
Rosa Gabriela Hernández-Cruz
DSDaniela Sánchez-Cobo
Daniela Sánchez-Cobo
SASandra Acevedo-Gallegos
Sandra Acevedo-Gallegos
Addy Cecilia Helguera-RepettoAddy Cecilia Helguera-Repetto
Addy Cecilia Helguera-Repetto
MRMario Roberto Rodriguez-Bosch
Mario Roberto Rodriguez-Bosch
Raigam Jafet Martinez Martinez-PortillaRaigam Jafet Martinez Martinez-Portilla
Raigam Jafet Martinez Martinez-Portilla
COVID-19 symptoms vary widely among pregnant women. We aimed to assess the most frequent symptoms amongst pregnant women with SARS-CoV-2 infection in a tertiary hospital in Mexico City.A cross-sect...